ATE521364T1 - Zusammensetzung und verfahren zur erhöhung der zelldichte in zellkulturen, die mit dem lentivirus infiziert sind - Google Patents

Zusammensetzung und verfahren zur erhöhung der zelldichte in zellkulturen, die mit dem lentivirus infiziert sind

Info

Publication number
ATE521364T1
ATE521364T1 AT02769679T AT02769679T ATE521364T1 AT E521364 T1 ATE521364 T1 AT E521364T1 AT 02769679 T AT02769679 T AT 02769679T AT 02769679 T AT02769679 T AT 02769679T AT E521364 T1 ATE521364 T1 AT E521364T1
Authority
AT
Austria
Prior art keywords
composition
lentivirus
cultures infected
cell cultures
cell density
Prior art date
Application number
AT02769679T
Other languages
English (en)
Inventor
Anne Christine Thomas
Terry Ng
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Application granted granted Critical
Publication of ATE521364T1 publication Critical patent/ATE521364T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02769679T 2001-05-10 2002-05-03 Zusammensetzung und verfahren zur erhöhung der zelldichte in zellkulturen, die mit dem lentivirus infiziert sind ATE521364T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29009601P 2001-05-10 2001-05-10
PCT/US2002/014271 WO2002091994A2 (en) 2001-05-10 2002-05-03 Composition and method for increasing cell density in cell cultures infected with lentivirus

Publications (1)

Publication Number Publication Date
ATE521364T1 true ATE521364T1 (de) 2011-09-15

Family

ID=23114512

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02769679T ATE521364T1 (de) 2001-05-10 2002-05-03 Zusammensetzung und verfahren zur erhöhung der zelldichte in zellkulturen, die mit dem lentivirus infiziert sind

Country Status (25)

Country Link
US (1) US7160721B2 (de)
EP (2) EP2298343A1 (de)
JP (1) JP4283544B2 (de)
KR (1) KR20040029981A (de)
CN (1) CN1326992C (de)
AT (1) ATE521364T1 (de)
AU (1) AU2002342568B2 (de)
BG (1) BG108315A (de)
BR (1) BR0209482A (de)
CA (1) CA2446131C (de)
CY (1) CY1112123T1 (de)
CZ (1) CZ20033046A3 (de)
DK (1) DK1385540T3 (de)
ES (1) ES2369846T3 (de)
HR (1) HRP20030974A2 (de)
HU (1) HUP0400283A2 (de)
MX (1) MXPA03010208A (de)
NO (1) NO20034961L (de)
NZ (1) NZ529326A (de)
PL (1) PL373847A1 (de)
PT (1) PT1385540E (de)
SI (1) SI1385540T1 (de)
WO (1) WO2002091994A2 (de)
YU (1) YU88703A (de)
ZA (1) ZA200309556B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10920483B2 (en) 2018-10-25 2021-02-16 Mark Mutchnik Window seal for preventing water penetration
EP4277933A4 (de) 2021-01-14 2024-12-11 Senti Biosciences, Inc. Sekretierbare nutzlastregulierung

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215107A (en) * 1978-12-29 1980-07-29 Merck & Co., Inc. Parainfluenza virus vaccine and its preparation
JPS57194787A (en) * 1981-05-28 1982-11-30 Ajinomoto Co Inc Culture medium for animal cell
US6107077A (en) 1987-08-26 2000-08-22 Yamamoto; Janet K. Feline lymphoid cell lines capable of producing FIV for FIV diagnostics and vaccines
AU640511B2 (en) * 1990-07-30 1993-08-26 Pharmacia & Upjohn Company Hexa-n-(o-hydroxybenzyl) neomycin b for inhibiting human retroviruses and for the treatment of aids
JPH08502966A (ja) * 1992-10-23 1996-04-02 ユニバーシティー・オブ・マサチューセッツ・メディカル・センター Ｒｎａ／リガンド結合の低分子抑制
US5534408A (en) * 1993-09-24 1996-07-09 University Of Massachusetts Medical Center 2-deoxystreptamine aminoglycoside inhibition of HIV RRE/Rev binding
PT759780E (pt) 1994-05-10 2001-01-31 American Home Prod Vacina melhorada de vsrb vivo modificado
DE69636440D1 (de) 1995-08-25 2006-09-21 Univ Florida IL-2 unabhängige T-Zellen der Katze

Also Published As

Publication number Publication date
JP4283544B2 (ja) 2009-06-24
CA2446131A1 (en) 2002-11-21
US20020197714A1 (en) 2002-12-26
CZ20033046A3 (en) 2004-03-17
DK1385540T3 (da) 2011-10-24
EP1385540B1 (de) 2011-08-24
CN1514734A (zh) 2004-07-21
PT1385540E (pt) 2011-10-21
WO2002091994A2 (en) 2002-11-21
SI1385540T1 (sl) 2011-10-28
CA2446131C (en) 2013-07-02
HRP20030974A2 (en) 2004-02-29
ZA200309556B (en) 2005-02-23
ES2369846T3 (es) 2011-12-07
MXPA03010208A (es) 2004-03-10
NZ529326A (en) 2006-09-29
NO20034961L (no) 2003-12-01
NO20034961D0 (no) 2003-11-07
CY1112123T1 (el) 2015-11-04
US7160721B2 (en) 2007-01-09
CN1326992C (zh) 2007-07-18
AU2002342568B2 (en) 2007-11-01
JP2005508139A (ja) 2005-03-31
BG108315A (bg) 2005-03-31
HUP0400283A2 (en) 2007-08-28
EP1385540A4 (de) 2004-12-01
EP1385540A2 (de) 2004-02-04
PL373847A1 (en) 2005-09-19
KR20040029981A (ko) 2004-04-08
YU88703A (sh) 2006-05-25
WO2002091994A3 (en) 2003-05-08
EP2298343A1 (de) 2011-03-23
BR0209482A (pt) 2007-01-02

Similar Documents

Publication Publication Date Title
AU2002212275A1 (en) Bio-reactor for the cultivation of micro-organisms and method for the production thereof
CY1108329T1 (el) Κυτταρικη καλλιεργεια
AU6155400A (en) Bioreactor
AU2002250670A1 (en) Improved culture vessel having non-flat surfaces for growing or culturing cells, cellular aggregates, tissues and organoids and methods for using same
AU2002336930A1 (en) Method for producing isolated cell cultures, culture medium for cultivating cell cultures and cell culture
NO20006096L (no) Medium for dyrking av dyreceller og fremgangsmåte for fremstilling av protein ved anvendelse av de samme
DE60029606D1 (de) Zellkulturspinnerflaschen
CA2543118A1 (en) Method for differentiating mesenchymal stem cell into neural cell and pharmaceutical composition containing the neural cell for neurodegenerative disease
TW200506058A (en) Method for culturing organic blue-green algae
ES2136099T3 (es) Induccion de celulas callosas y preparacion de taxanos.
ATE521364T1 (de) Zusammensetzung und verfahren zur erhöhung der zelldichte in zellkulturen, die mit dem lentivirus infiziert sind
EP1627910A4 (de) Vorrichtung zur kultivierung eines organismus und kulturverfahren
AU2003206926A1 (en) Cultivation method for micro-organisms and bioreactor
ATE414141T1 (de) Verfahren zur kultivierung humaner chondrozyten
DE60129547D1 (de) Verfahren zur kultivierung von mikroorganismen
DE69520098D1 (de) Methode zur kontrolle der metallophosphatpraezipitation in fermentationen mit hoher zelldichte
WO1996007730A3 (de) Chemisches verfahren zur förderung der proliferation von tierischen zellen
EP1176194A4 (de) Verfahren der zellkultivierung
ATE230434T1 (de) Vorrichtung zum kultivieren von mikroorganismen
WO2002064811A3 (fr) Procede pour produire des proteines recombinantes, marquees par au moins un isotope
AU2182801A (en) Method for producing adherent animal cells
AU6262786A (en) Growing aids virus in cell lines lacking human class ii histocompatability antigens
ATE204508T1 (de) Mikrobiologisches verfahren zur beseitigung von halogenierten ethenen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1385540

Country of ref document: EP